Tetrabenazine transdermal delivery device
AssigneeShinkei Therapeutics, Inc.
InventorsSuresh BORSADIA, Kalpana PATEL, Hock S. TAN
Life of this patent
Estimating the term…
Abstract
Provided herein are transdermal delivery devices comprising tetrabenazine, a deuterated tetrabenazine, or a combination thereof. Also provided herein are pharmaceutical compositions, such as adhesive compositions, comprising tetrabenazine, a deuterated tetrabenazine, or a combination thereof, for example, homogenously dispersed in an adhesive, such as a pressure sensitive adhesive. Further provided herein are methods of using the transdermal delivery devices or pharmaceutical compositions, for example, for treating a hyperkinetic movement disorder.
Claims22
An adhesive composition comprising:
- an active ingredient dispersed in a non-reactive acrylate pressure sensitive adhesive,
- wherein the active ingredient is selected from tetrabenazine, deuterated tetrabenazine, or a combination thereof,
- wherein the non-reactive acrylate pressure sensitive adhesive is in an amount of about 50% to about 97% by weight.
-5. (canceled)
-10. (canceled)
-24. (canceled)
A method of treating a hyperkinetic movement disorder in a subject in need thereof, the method comprising transdermally administering a therapeutically effective amount of tetrabenazine or deuterated tetrabenazine to the subject.
Dependencies are inferred from the claim text.